CHICAGO — Since its debut on Jan. 1, 2013, the American Academy of Ophthalmology’s Intelligent Research in Sight Registry has become the world’s largest clinical registry, William L. Rich III, MD, said in a press briefing at the American Academy of Ophthalmology meeting.The registry provides ophthalmologists with data on more than 28 million U.S. patients and 100 million patient visits, according to Rich.
CHICAGO — A healthy cornea, optimal tear function, accurate devices capable of taking both anterior and posterior measurements, and ways to noninvasively adjust postoperative refraction can help a surgeon accurately record cornea measurements and IOL calculations, Douglas D. Koch, MD, said in his delivery of the Jackson Memorial Lecture here.“The requirement that we have for reducing and managing corneal measurement errors, is, of course, [that] our patient’s corneas need to be optimized. They need to be as healthy as possible with optimal tear function,” Koch said at the American Academy (Read more...)
CHICAGO — Patients whose indication for implantation of a Boston Type 1 keratoprosthesis was Stevens Johnson syndrome had a higher retention failure rate than other patients implanted with the device for other reasons, according to study results presented here. At Cornea Subspecialty Day preceding the American Academy of Ophthalmology meeting, Anthony J. Aldave, MD, reported his experience with the device in a retrospective, single surgeon consecutive case series.
CHICAGO — Topical natamycin remains the mainstay of treatment of fungal ulcers, a treatment developed in the 1960s, a speaker here said. “However, Fusarium ulcers may benefit from the addition of oral voriconazole,” Jennifer R. Rose-Nussbaumer, MD, said at Cornea Subspecialty Day preceding the American Academy of Ophthalmology meeting. “That needs to be balanced with the fact that it does have higher adverse events and is expensive.”
CHICAGO — Searching for and treating biomarkers is an important part of conjunctival melanoma management, according to a presenter here.“Management of conjunctival melanoma is more than removing the lump on the surface of the eye,” Carol L. Shields, MD, said at Cornea Subspecialty Day preceding the American Academy of Ophthalmology meeting. “Now we look for molecular markers in all patients to identify high-risk melanoma, because we have medications for biomarkers.”
CHICAGO — At the American Academy of Ophthalmology meeting, Caesar Luo, MD, reports outcomes of patients with diabetic macular edema treated with the Lumenis Smart 532 photocoagulator. The laser was launched at the meeting here.